Overview

Efficacy of Focal Primaquine Mass Administration for Eliminating Plasmodium Vivax Malaria in Northern Myanmar

Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2024-12-31
Target enrollment:
Participant gender:
Summary
Plasmodium vivax has become the predominant species in the Greater Mekong Subregion and is a major challenge for regional malaria elimination. Mass primaquine administration has played a decisive role in malaria elimination in many temperate zone countries, but its efficacy in tropical areas remains to be evaluated. This study aims to assess the efficacy of targeted primaquine mass treatment (TPT) for eliminating P. vivax malaria in northern Myanmar.
Phase:
NA
Details
Lead Sponsor:
Pyae Linn Aung
Collaborators:
Mahidol University
University of South Florida
Treatments:
Primaquine